EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Transglutaminase 2 Preserves Blood–Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice

Jieru Yang iD, Lihan Zhang, Xiancheng Qiu iD, Jiyang Wang, Ruicheng Yan, Jiasen Ye, Jianhua Peng iD, Yong Jiang iD

CNS Neuroscience & Therapeutics · 2026

DOI: 10.1002/cns.70887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Jieru Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, the Affiliated Hospital, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Brain Injuries, Traumatic, Transglutaminases, GTP-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Scientific Research Project of the Sichuan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Traumatic brain injury (TBI) is a leading global cause of disability and mortality, with blood–brain barrier (BBB) disruption exacerbating secondary injury. Transglutaminase 2 (TGM2), a multifunctional enzyme implicated in neuroinflammation and extracellular matrix remodeling, remains underexplored in TBI‐related BBB dysfunction. This study elucidates the role of TGM2 in BBB disruption following TBI and explores its therapeutic potential in mitigating BBB damage.

Methods

The controlled cortical impact (CCI) and oxygen–glucose deprivation (OGD) models were used to establish in vivo and in vitro TBI models in mice. The experimental approaches comprised RNA sequencing, Western blot analysis, RT‐qPCR, immunofluorescence staining, and behavioral assessments.

Results

TGM2 expression peaked at 48 h after TBI, predominantly in brain endothelial cells, correlating with BBB disruption (reduced tight junction proteins, increased edema). TGM2 knockdown may attenuate MMP‐9 via the IL‐17 pathway, restoring BBB integrity. In vivo, TGM2 inhibition reduced Evans blue leakage, upregulated CLAUDIN‐5/ZO‐1, and improved motor coordination, balance, and spatial memory.

Conclusion

TGM2 is a key molecule affecting the BBB after TBI. Inhibition of TGM2 can alleviate the blood–brain barrier and neurological deficits after TBI, acting through the IL‐17‐MMP‐9 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierBrain Injuries, TraumaticTransglutaminasesGTP-Binding ProteinsAnimalsProtein Glutamine gamma Glutamyltransferase 2MiceMaleMice, Inbred C57BLDisease Models, AnimalEndothelial Cells

Stichwörter der Autor:innen

IL‐17MMP‐9blood–brain barriertransglutaminase 2traumatic brain injury

Substanzen

Protein Glutamine gamma Glutamyltransferase 2TransglutaminasesGTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, the Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Laboratory of Neurological Diseases and Brain Function, the Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Clinical Trial Research Center, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
  • Academician (Expert) Workstation of Sichuan Province, the Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Institute of Brain Science, Southwest Medical University, Luzhou, China.
  • Sichuan Clinical Research Center for Neurosurgery, the Affiliated Hospital, Southwest Medical University, Luzhou, China.

ORCID-Profile: Jieru Yang, Xiancheng Qiu, Jianhua Peng, Yong Jiang

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program
  • Scientific Research Project of the Sichuan Provincial Health Commission
  • Luzhou Government-Southwest Medical University Cooperation Project
  • Southwest Medical University Project
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Yang, J., Zhang, L., Qiu, X., Wang, J., Yan, R., Ye, J., Peng, J., & Jiang, Y. (2026). Inhibition of Transglutaminase 2 Preserves Blood–Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70887

Vancouver

Yang J, Zhang L, Qiu X, Wang J, Yan R, Ye J, et al. Inhibition of Transglutaminase 2 Preserves Blood–Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70887

BibTeX
@article{Yang2026,
  author = {Yang, Jieru and Zhang, Lihan and Qiu, Xiancheng and Wang, Jiyang and Yan, Ruicheng and Ye, Jiasen and Peng, Jianhua and Jiang, Yong},
  title = {Inhibition of Transglutaminase 2 Preserves Blood–Brain Barrier Integrity and Improves Neurological Outcomes After Experimental Traumatic Brain Injury in Mice},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  doi = {10.1002/cns.70887}
}
Kostenlos starten →